The term paraproteinemic neuropathy describes a heterogeneous set of neuropathies characterized by the presence of homogeneous immunoglobulin in the serum. An abnormal clonal proliferation of B ...

Regenacy Pharmaceuticals is developing a novel, disease-modifying approach to treating peripheral neuropathies that goes beyond pain and symptom management to restore peripheral nerve function.

In the first presentation of this GEN webinar, our expert speaker Devansh Agarwal will present results from a study and how the scientists generated RGC-like induced neurons in under a week by ...